INTRODUCTION:

Transdermal sedate conveyance frameworks are topical details in the frame of patches that discharge pharmaceuticals to achieve systemic impacts at a controlled and foreordained rate. These transdermal medicine conveyance frameworks have been in presence for very a long time. The most seasoned and most commonly utilized procedures for the treatment of skin-related disarranges were the application of moisturizers and treatments topically.

Transdermal sedate organization is the non-invasive conveyance of drugs to the circulation framework from the external cover of the skin, that is, the biggest most open organ of the human body. TDDS brags a few focal points over the customary strategies of injectable and verbal frameworks. Transdermal medicate conveyance not as it were permits a controlled, consistent sedate conveyance handle but moreover permits for the proceeded mixture of drugs with brief half-lives in the human body and anticipates beat section into systemic circulation, a condition that regularly leads to harmful side effects.

The essential objective of a transdermal conveyance framework for pharmaceutical is that pharmaceuticals be conveyed through the skin into systemic circulation at a foreordained rate with negligible associate and intra-patient vacillation.

Today, transdermal conveyance is among the most promising pharmaceutical conveyance modalities. It eases the strain that the verbal course habitually causes on the stomach related tract and liver. It makes strides understanding compliance and decreases the perilous side impacts of a medication delivered by a temporal overdose, and it is helpful in transdermal managed drugs that require fair a single frail application.

The transdermal sedate organization has a basic advantage in terms of limiting the hepatic first-pass digestion system, increase of helpful viability, and keeping up a plasma level of pharmaceutical that is decently stable.

TDDS is a multidisciplinary movement of crucial possibility thinks about beginning with the choice of the medicate particle and finishing with the exhibit of adequate sedate flux in an ex vivo and in vivo show, taken after by the manufacture of a sedate conveyance framework that meets all of the exacting needs that are particular to the medicate particle (physicochemical, steadiness variables), the understanding (consolation and restorative request), the producer (scale up and fabricating), and the quiet (consolation and corrective appeal)^1,6.

ANATOMY OF SKIN:

Figure 1. Anatomy of skin

The skin is the most observable and the largest organ in the human body. Its surface area is 1.7 m2 and accounts for 16% of the average mass of a human being. The main job of the skin is to guard the body from bacteria, ultraviolet radiation, chemicals, allergies, and water loss. The skin has three layers:

(1) The epidermis, which includes the stratum corneum.

(2) The dermis, which is the middle layer.

(3) The hypodermis, which is the innermost layer.

Epidermis:

The epidermis is the outermost layer of the skin and varies in thickness from 0.8mm on the palms of the hands to the soles of the feet. It consists of multi-layered epithelial cell areas, and the viable epidermis is sometimes referred to as the epidermal layers underneath the stratum corneum. The cellular composition of the epidermis is dominated by keratinocytes, which constitute 95% of cells in this layer. Other layers of the epidermis are composed of melanocytes, Langerhans cells, and merkel cells. The stratum corneum is the superficial epithelium of the skin. It is exposed directly to the environment; thus, its barrier features might be partly due to its very high density (1.4g/cm3 in the dry state) and its low hydration of 15%-20%. The stratum corneum is composed of insoluble keratins (70%) and lipid (20%). Water is bound to keratin in corneocytes in the stratum corneum^10,13.

Dermis:

The dermis is approximately 2-3mm in thickness and comprises collagenous (70%) and elastin fibers, giving strength and suppleness to the skin. Dermal blood veins give nutrition to both dermis and epidermis. As illustrated in, the layer of dermis contains nerves, macrophages, and lymphatic veins¹⁰.

Hypodermis:

The hypodermis, or the subcutaneous layer, is the thinnest layer of skin, consisting of a layer of fat cells that serves as a network of cellular layers. It is known to be the layer from which the underlying tissues-the muscles and bones-burst out. Consequently, the main roles of the hypodermis include physical shock protection, thermal insulation, and support and conductance of the skin's vascular and neurological impulses. Fat cells, which reside in the hypodermis, comprise approximately 50% of body fat, with fibroblasts and macrophages forming the other significant hypodermis cells¹³.

Transcutaneous routes for drug penetration:

Intact skin allows two potential pathways for drug penetration: the trans epidermal and transappendegeal routes. The trans epidermal route allows molecules to translocate through the stratum corneum, a multi-layered barrier with an architecturally varied form. Trans epidermal penetration can occur intra- or inter-cellularly. Corneocytes allow the intracellular movement of hydrophilic or polar solutes; corneocytes are terminally differentiated keratinocytes. Transport across intercellular gaps allows lipophilic or non-polar solutes to diffuse through the continuous lipid matrix. The transappendegeal pathway includes molecules passing through sweat glands and over hair follicles¹⁶.

ADVANTAGES OF TDDS:

1) Transdermal medication avoids gastrointestinal absorption and its associated risks of inactivation by enzymes or pH.

2) It avoids first-pass metabolism.

3) Medications that typically require constant plasma levels make good candidates for transdermal drug delivery because reduced peaks in plasma concentration decrease the probability of adverse effects.

4) An alternative to the oral route

5) Actually, the patch allows for continuous dosage instead of the peaks and valleys that occur with orally delivered drugs.

6) Thus, rapid notifications of medications during emergency cases and quick withdrawal of effects through patch removal can easily be done.

7) Preventing gastro-intestinal incompatibility.

8) Utility is observed in patches most especially where it requires only one application in a week; this simple dosage unit will aid in bringing compliance towards pharmacological therapy on the part of patients³.

DISADVANTAGES OF TDDS:

1) No transdermal route exists for ionic medications to be delivered.

2) It is unsuccessful in attaining high drug levels in blood.

3) Cannot develop for drugs of large molecular size.

4) It is unable to distribute medications in a pulsatile manner.

5) It cannot form if the medicine or formulation causes skin irritation.

6) Local irritation at the application site is possible.

7) An allergic reaction is possible.

8) Long-term compliance is difficult¹⁶.

Factors Affecting Transdermal Permeation:

Biological factors:

1) Skin condition

2) Skin age

3) Blood supply

4) Regional skin site

5) Skin metabolism

6) Species differences

Physicochemical factors:

1) Skin hydration

2) Temperature and pH

3) Diffusion coefficient

4) Drug concentration

5) Partition coefficient

6) Molecular size and shape

Environmental factors:

1) Sunlight

2) Cold season

3) Air pollution

Skin condition:

Normal intact skin functions as a protective barrier, but many solvents in their act of penetrating cells can be used to affect drug absorption. Such solvents, amongst which methanol and chloroform are common examples, will dissolve the lipid part, allowing the formation of artificial shunts into which drug molecules can pass easily⁷.

Age of the skin:

Children and younger adults have more porous skin than older persons; however, the difference is minor. The greater skin surface area in cases of very young individuals leads to increased toxic effects. This, therefore, accounts for many serious side effects associated with powerful steroids, boric acid, and hexachlorophene¹.

Blood supply:

Peripheral circulation alterations may influence transdermal absorption¹.

Regional site on the skin:

Different location impacts skin thickness, stratum corneum composition, and both number and types of appendages; all of which affect penetration¹.

Skin metabolism:

The skin is responsible for the metabolism of steroids, hormones, chemical carcinogens, and certain medications, which affect the efficacy of transdermal drugs based on their skin metabolism. The metabolism influences the effectiveness of drugs absorbed through the skin. The differences in skin thickness, density of appendages, and keratinization of the skin vary from species to species, hence influencing penetration⁷.

Skin hydration:

Permeability is increased by hydration with water. Hydration has the largest influence on skin permeability. Therefore, humectants have a role to play in transdermal distribution¹.

Temperature and pH:

The permeability of drugs is increased tenfold by a slight increase in temperature. The coefficient of diffusion undergoes a decrease with the decrease in temperature. The principal influence of pH, as well as pKa and pKb values, lies in their degree of ionization of weak acids and bases, which, in conjunction with their concentrations, directs the amount of drug in the skin. Therefore, temperature and pH are important factors concerning drug penetration⁷.

Diffusion coefficient:

The extent of penetration is dependent upon the value of diffusion coefficient. The diffusion coefficient of a drug at constant temperature is derived from the characteristics of the drug, the characteristics of the medium, and the interaction of the drug with the medium⁷.

Drug concentration:

The flow across the barrier is relied on the concentration gradient above it-an increase in the concentration across the barrier will enhance the concentration gradient¹.

Partition coefficient:

The partition coefficient ideal (K) is critical for the desirable function of the drugs. Drugs with a high K are still not ready to leave the lipid zone of the skin. Likewise, drugs with a low K will stay out of the skin altogether⁷.

Molecular size and shape:

Drug absorption will inversely depend on molecular weight; small molecules penetrate faster than large molecules¹.

Sunlight:

When the skin is sunburnt, it loses the elasticity of its blood vessel walls. As a result of the exposure of the sun, the normal bruising usually arises with little damage to the skin. The most common form of visible sun-induced change is a freckle or solar lentigo¹.

Winter:

This leads to itchy and dry skin. To compensate for the drying effect of the weather, there is oil production by the skin, and a good moisturiser will relieve dry skin. Water also goes a long way in helping keep the skin moisturised and healthy¹.

Air Pollution:

Dust may block pores and grow a microbe on the surface of the face and skin, thus bringing on problems somewhat related to acne and the development of patches. This affects the distribution of medicines through the skin. Invisible chemical pollutants in the air may affect the natural defense of the skin by breaking down the natural oils that encase moisture in the skin and keep it supple⁷.

Types of Transdermal Patches:

1) Single layer drug in adhesive:

In this case, the drug is included in the adhesive layer. The adhesive layer not only bonds the various layers together, but it is also responsible for delivering the medicine to the skin. An interim liner and a backing surround the adhesive layer¹⁴.

Figure 2. Single layer drug in adhesive

2) Multi-layered drug in adhesive: In this case, the drug is included in the adhesive layer. The adhesive layer is responsible for retaining the various layers in position, as well as for supplying medication to the skin. An interim liner and backing encompass the adhesive layer¹⁴.

Figure 3. Multi-layered drug in adhesive

3) Vapor patch: An adhesive layer in these kinds of patches serves both to stick the various layers together and to release vapors. The vapor patch market is relatively new⁸.

4) Reservoir system: The drug reservoir of this device is placed between an impermeable backing layer and a rate-controlling membrane. Only the rate-controlling membrane, which can be porous or non-porous, allows the medicine to be deployed. The drug can be in the form of a solution, suspension, gel, or distributed in a solid polymer matrix in the drug reservoir compartment. A polymeric membrane that is medication compatible, hypoallergenic adhesive polymer can be used as an exterior surface¹¹.

Figure 4. Reservoir system

5) Micro-reservoir system: The drug-distributing system in this type is hybridized between a reservoir and a matrix-dispersion system. The drug reservoir is formed by incorporating a drug into an aqueous solution of a water-soluble polymer and homogeneously spreading the solution in a lipophilic polymer, thereby forming thousands of inaccessible, tiny drug-reservoir spheres. Within a very short period, this thermodynamically unstable dispersion can be rapidly stabilised by cross-linking the polymer in situ with cross-linking agents¹¹.

Figure 5. Micro-reservoir system

Components of Transdermal Patch:

Figure 6. Components of TDD

METHODS USED FOR PREPARING TRANSDERMAL PATCHES:

Asymmetric TPX membrane method: The backing membrane for this prototype patch will be a 1cm concave polyester sheet with heat sealable properties. The sample drug is poured into the concave membrane, which is then covered with an asymmetric membrane and sealed with an adhesive. [(Asymmetric TPX Membrane Preparation): They are prepared by dry/wet inversion technique. A polymer solution is created at 60°C by dissolving TPX in a mixture of solvents (cyclohexane) and nonsolvent materials⁹.

Circular teflon mould method: In organic solvents, polymer solutions in different ratios are used. The amount of drug calculated is dissolved in half of the same organic solvent. After this, enhancers in various concentrations are dissolved in the remaining organic solvent and added. A plasticizer is added into the drug-polymer solution. The mixture should be stirred for 12 hours before it is poured into the circular Teflon mould. The moulds must be kept on a leveled surface and covered with an inverted funnel in order to control solvent vapourisation in a laminar flow hood model with an air speed of 0.5 m/s for 24 hours of the solvent evaporation⁹.

Mercury substrate method: The medicine is dissolved in the polymer solution along with a plasticizer. The above-mentioned solution is stirred for 10-15 minutes to form a homogenous dispersion and is spread over a leveled mercury surface, covered by an inverted funnel to control the rate of evaporation of the solvent⁹.

EVALUATION OF TRANSDERMAL PATCHES:

· Physiochemical evaluation

· In-vitro evaluation

· In-vivo evaluation

Physiochemical evaluation:

1) Thickness: The thickness of transdermal patch is measured at several spots on the patch using a travelling microscope, dial gauge, screw gauge, or micrometre⁵.

Figure 7. Screw gauge

2) Uniformity of weight: Weight fluctuations can be assessed by taking the average weight of 10 random patches selected and weighed; individual weights should not differ substantially from this average^4,5.

3) Drug content determination: Accurately weighing about 100 mg of the film and dissolving it in 100 ml of an appropriate solvent in which the compound dissolves-solvent-24 hours continuously shaken on a shaker incubator. The solution is then subjected to sonication. After the sonication, the solution is then filtered and the drug quantitated spectrophotometrically after proper dilution⁵.

Figure 8. UV spectroscopy

4) Moisture content: The resulting films are individually weighed and stored at room temperature in desiccators containing calcium chloride for 24 hours. They get weighed again at specific time intervals until they achieve a constant weight^4,5.

In-vitro evaluation:

1) The paddle over disc: The transdermal system is coupled to a disc or cell sitting at the bottom of the vessel, which holds medium at 32.5°C¹⁷.

2) The cylinder modified USP basket: This system is similar to the USP basket type dipping device, except that the system is attached to the inner wall of a hollow cylinder immersed in medium at 35 degrees C. The reason for this variability is due to the fact that the amount of drug available for systemic absorption is determined by the amount of drug released from the polymer transdermal films. Drug penetrates the epidermal cells and between the epidermal cells into dermal microcirculation by skin appendages².

3) Franz Diffusion cell: A diffusion cell could be utilized for an in vitro study concerning a permeability investigation. Male Westar rats weighing between 200 and 250 grams were used. So, to depilate the hairs, clip hairs with electric clippers. Thoroughly wash the dermal side with distilled water to remove any adherent residue of tissues or blood vessels. Before the experiment, equilibrate for one hour either in the dissolution medium or phosphate buffer pH 7.4, and then place it on a magnetic stirrer that has a small magnetic needle for uniform diffusion of the diffusant. The temperature of the cell is maintained at 32 ± 0.5° C using a thermostatically controlled heater. The isolated rat skin piece is mounted between the compartments of the diffusion cell, the epidermis facing upwards into the donor compartment as using a given volume of constant volume sample for removal from the receptor compartment at regular intervals, and fresh medium should be replaced with equal volumes. Filter the samples through the filtering medium; they can be spectrophotometrically analyzed or by HPLC. Flux would be measured directly as the slope of the curve between the steady-state values of the amount of drug permeated (mg cm-2) versus time in hours, and permeability coefficients were deduced by dividing the flux by the initial drug load (mg cm-2)¹⁷.

In-vivo evaluation:

1) Animal models: Studies based on humans often require so much time and resources that one believes it is easier to use an animal model that is much smaller in size. Major animal species under investigation for transdermal drug delivery systems are: mouse hairless rat, hairless dog, hairless rhesus monkey, rabbit, guinea pig, etc. It has been discovered in experimental conditions that hairless vertebrates tend to show more promise with both in vitro and in vivo experiments. The Rhesus monkey is derived as the best possible reliable model for in vivo evaluation transdermally in humans¹⁵.

CONCLUSION:

The area of transdermal drug delivery is expanding rapidly due to its large multitude of advantages, thus triggering various studies to combine more and more drugs via transdermal routes. Normally, drugs have to permeate through the skin in order to achieve systemic effects. In view of the fact that skin is a barrier to drug permeation, permeation enhancers have been used to enhance the permeability of poorly absorbed drugs and hence maintain their bioavailability. The present review summarizes the plethora of NPEs that may be used to invoke acceleration or penetration of drugs across skin for the development of transdermal delivery systems and parameters for conducting permeation testing. Various NPEs have been addressed in this article that can be employed to increase drug absorption over skin for the creation of TDDS.

REFERENCE:

1. Rastogi, Vaibhav, and Pragya Yadav. Transdermal drug delivery system: An overview. Asian Journal of Pharmaceutics (AJP). 2012; 6(3).

2. Gadekar, Radhika, et al. Study of formulation, characterisation and wound healing potential of transdermal patches of curcumin. Asian J Pharm Clin Res. 2012; 5(4): 225-30.

3. Alam, Aftab, et al. Role of Transdermal Drug Delivery System. Asian Journal of Pharmaceutical Research and Development. 2021; 9(3): 137-143.

4. Dhiman, Sonia, Thakur Gurjeet Singh, and Ashish Kumar Rehni. Transdermal patches: a recent approach to new drug delivery system. Int J Pharm Pharm Sci. 2011; 3(5): 26-34.

5. Saroha, Kamal, Bhavna Yadav, and Benika Sharma. Transdermal patch: A discrete dosage form. Int J Curr Pharm Res. 2011; 3(3): 98-108.

6. Ramadon, Delly, et al. Enhancement strategies for transdermal drug delivery systems: Current trends and applications. Drug Delivery and Translational Research. 2021: 1-34.

7. Gaur, P. K., et al. Transdermal drug delivery system: a review. Asian Journal of Pharmaceutical and Clinical Research. 2009; 2(1): 14-20.

8. Sharma, Nikhil, et al. Blooming pharma industry with transdermal drug delivery system. Indo Global J Pharm Sci. 2012; 2(3): 262-278.

9. Teja, Sharma, and Rawal Gaurav. Transdermal Therapeutic Systems, An overview. International Journal of Pharmaceutical and Biological Archives. 2011; 2(6): 1581-1587.

10. Richhariya, Aadarsh, Nitendra Rohit, and Yuvraj Singh Dangi. International Journal of Modern Pharmaceutical Research.

11. Shukla, Mukesh Kumar, Kirti Shukla, and Harshit Srivastava. A Review on Transdermal Patches. 2023.

12. Mujoriya, Rajesh, and K. A. Dhamande. Review on transdermal drug delivery system. Res J Sci Tech. 2011; 3(4): 227-31.

13. Lade, Swati, Satish Kosalge, and Surfraj Shaikh. Transdermal drug delivery system: a tool for novel drug delivery system: an overview. World J Pharm Res. 2013; 3(2): 1892-1908.

14. Jassim, Zainab E., Halah Talal Sulaiman, and Saba Abdul Hadi Jabir. Transdermal drug delivery system: A review. J Pharm Res. 2018; 12(5): 802.

15. Alam, Md Intakhab, et al. Type, preparation and evaluation of transdermal patch: a review. World Journal of Pharmacy and Pharmaceutical Sciences. 2013; 2(4): 2199-2233.

16. Reddy, Y. Krishna, D. Maheswara Reddy, and M. Asok Kumar. Transdermal drug delivery system: a review. Indian Journal of Research in Pharmacy and Biotechnology. 2014; 2(2): 1094.

17. Vishwakarma, Ajit Kumar, et al. Pharmacy Review and Research.

Received on 05.12.2024 Revised on 02.01.2025

Accepted on 22.01.2025 Published on 28.02.2025

Available online from March 03, 2025

Asian J. Pharm. Res. 2025; 15(1):87-93.

DOI: 10.52711/2231-5691.2025.00015

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.

Components	Example	Use
Drug	Drug of choice	It is used for active therapeutic agent.
Polymer matrix	nitroglycerine	Polymers are the backbone of TDDS, which control the release of the drug from the device.
Permeation enhancer	Natural: saponins, Laureth-9 (surfactant); fusidic acid derivatives, trihydroxy salts (bile salts); oleic acid, caprylate, laurate (fatty acid); EDTA, salicylic acid (chelators); phospholipids, etc.	Permeation enhancers are the compounds which promote skin permeability.
Pressure sensitive adhesive	polyacrylate copolymers (acrylics), polysiloxanes (silicones) and polyisobutylenes (PIBs)	To help in adhesion of patch to skin.
Backing laminates	Ex: vinyl, Polyester-polypropylene films, polyester films, Polypropylene resin, and Aluminized plastic laminate.	The outermost layer of the patch, which protects the formulation during the wear period.
Release liner	Ex: Silicon or Teflon Other materials: polyesters, foil and metallized laminates.	A release liner is a web of sheet material that covers the adhesive side of a pressure sensitive adhesive (PSA) tape product to provide a protective surface during storage and transit, as well as to provide functional support during manufacturing and converting.
Other recipients like plasticizers and solvents	Plasticizers such as dibutylpthalate, triethylcitrate, polyethylene glycol and propylene glycol	Added to provide plasticity to the transdermal patch^12,16.